These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8794412

  • 1. Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
    Kimura H, Yamaguchi Y.
    Lung Cancer; 1996 Jun; 14(2-3):301-14. PubMed ID: 8794412
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
    Kimura H, Yamaguchi Y.
    Lung Cancer; 1995 Aug; 13(1):31-44. PubMed ID: 8528638
    [Abstract] [Full Text] [Related]

  • 3. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H, Yamaguchi Y.
    Cancer; 1997 Jul 01; 80(1):42-9. PubMed ID: 9210707
    [Abstract] [Full Text] [Related]

  • 4. Intermittent adjuvant chemo-immunotherapy after resection of non-small cell lung cancer with multilevel mediastinal lymph node metastasis.
    Suzuki M, Kimura H, Iwai N, Fujisawa T.
    Oncol Rep; 2000 Jul 01; 7(3):545-9. PubMed ID: 10767366
    [Abstract] [Full Text] [Related]

  • 5. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
    Scagliotti GV, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M, Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators.
    J Natl Cancer Inst; 2003 Oct 01; 95(19):1453-61. PubMed ID: 14519751
    [Abstract] [Full Text] [Related]

  • 6. [Adoptive immunotherapy with LAK cell and IL-2 against primary lung cancer].
    Kimura H, Yamaguchi Y.
    Nihon Geka Gakkai Zasshi; 1989 Sep 01; 90(9):1459-62. PubMed ID: 2586439
    [Abstract] [Full Text] [Related]

  • 7. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M, Tsushima T, Ito H, Fukuda Y, Maruyama A, Fujita H, Yagihashi N, Tsuge T, Ishioka T, Kudo T, Kishibe S, Sato T, Machida S, Kogawa R, Takashima K, Koie H, Fujita K.
    Gan To Kagaku Ryoho; 1996 Feb 01; 23(3):303-9. PubMed ID: 8712823
    [Abstract] [Full Text] [Related]

  • 8. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul 01; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 9. Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.
    Kimura H, Matsui Y, Ishikawa A, Nakajima T, Yoshino M, Sakairi Y.
    Cancer Immunol Immunother; 2015 Jan 01; 64(1):51-9. PubMed ID: 25262164
    [Abstract] [Full Text] [Related]

  • 10. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H, Kitagawa C, Ichinose Y, Takenoyama M, Ibata H, Kato T, Takami K, Yamashita M, Maeda T, Takeo S, Ueda H, Okabayashi K, Nagashima S, Oka T, Kouso H, Fukuyama S, Yoshimoto K, Shimokawa M, Saito AM, Ito S.
    Trials; 2017 Sep 15; 18(1):429. PubMed ID: 28915900
    [Abstract] [Full Text] [Related]

  • 11. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
    Wada H, Miyahara R, Tanaka F, Hitomi S.
    Eur J Cardiothorac Surg; 1999 Apr 15; 15(4):438-43. PubMed ID: 10371118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Postsurgical adjuvant immunotherapy against primary non-small cell lung cancer].
    Kimura H, Iwai N, Suzuki M, Takahashi Y.
    Nihon Geka Gakkai Zasshi; 1998 May 15; 99(5):279-84. PubMed ID: 9656236
    [Abstract] [Full Text] [Related]

  • 14. Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
    Kimura H, Iizasa T, Ishikawa A, Shingyouji M, Yoshino M, Kimura M, Inada Y, Matsubayashi K.
    Anticancer Res; 2008 May 15; 28(2B):1229-38. PubMed ID: 18505060
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 15; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
    Nakagawa K, Tada H, Akashi A, Yasumitsu T, Iuchi K, Taki T, Kodama K, Osaka Lung Cancer Study Group, Japan.
    Br J Cancer; 2006 Oct 09; 95(7):817-21. PubMed ID: 16969350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
    Wada H, Hitomi S, Teramatsu T.
    J Clin Oncol; 1996 Apr 09; 14(4):1048-54. PubMed ID: 8648356
    [Abstract] [Full Text] [Related]

  • 20. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH, Kim YB, Lim HY, Park JS, Kim HC, Cho YK, Han SW, Kim MW, Joo HJ.
    Hepatogastroenterology; 2007 Apr 09; 54(73):290-7. PubMed ID: 17419278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.